Urinary Tract Infection (UTI) Drugs are used for the treatment of urinary tract infection caused by bacterial or fungal infections.
It has further been stated that chances of boys being diagnosed with UTI is 1% while chances of girls being diagnosed with Urinary Tract Infection (UTI) is 3 to 8%.
On the other hand, market constraints include excellent efficacy of present antibiotics specially quinolones, growing drug resistance, unmet clinical needs, increasing incidence of chronic diseases etc.
Request Free Sample Report at: https://www.marketresearchfuture.com/sample_request/2540
However, the rise of drug resistance has created the need for novel acting antibiotic.
The future of Urinary Tract Infection (UTI) treatment seems to be development of biologics with greater market development especially with respect to poorly growing African market.